BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

506687

TRANSPEK

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

TRANSPEK INDUSTRY LTD. Share Price Update

As of the latest trading session, TRANSPEK INDUSTRY LTD. share price is currently at ₹ 1405.05, which is up by ₹ 6.00 from its previous closing. Today, the stock has fluctuated between ₹ 1399.85 and ₹ 1410.00. Over the past year, TRANSPEK INDUSTRY LTD. has achieved a return of -19.75 %. In the last month alone, the return has been -13.76 %. Read More...

Investment Returns

Over 1 Month -13.76% Over 3 Months -10.98% Over 6 Months 10.80% Over 1 Year -19.75%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

TRANSPEK INDUSTRY LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    781.40

  • P/E Ratio (TTM)

    14.32

  • Beta

    0.56

  • Book Value / share

    1,334.39

  • Return on equity

    7.68%

  • EPS (TTM)

    98.52

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    15.58

info icon alternate text

TRANSPEK INDUSTRY LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 154.23
Operating Expense 144.97
Net Profit 15.58
Net Profit Margin (%) 10.10
Earnings Per Share (EPS) 27.90
EBITDA 35.71
Effective Tax Rate (%) 25.56
Particulars MAR 2025 (Values in Cr)
Revenue 165.26
Operating Expense 148.47
Net Profit 19.25
Net Profit Margin (%) 11.64
Earnings Per Share (EPS) 34.47
EBITDA 39.95
Effective Tax Rate (%) 21.49
Particulars DEC 2024 (Values in Cr)
Revenue 170.04
Operating Expense 161.35
Net Profit 10.65
Net Profit Margin (%) 6.26
Earnings Per Share (EPS) 19.06
EBITDA 28.83
Effective Tax Rate (%) 21.57
Particulars SEP 2024 (Values in Cr)
Revenue 162.70
Operating Expense 155.89
Net Profit 9.55
Net Profit Margin (%) 5.86
Earnings Per Share (EPS) 17.10
EBITDA 27.60
Effective Tax Rate (%) 19.68
Particulars JUN 2024 (Values in Cr)
Revenue 151.86
Operating Expense 151.17
Net Profit 9.29
Net Profit Margin (%) 6.11
Earnings Per Share (EPS) 16.63
EBITDA 26.99
Effective Tax Rate (%) 20.32
Particulars MAR 2025 (Values in Cr)
Revenue 649.85
Operating Expense 616.90
Net Profit 48.74
Net Profit Margin (%) 7.50
Earnings Per Share (EPS) 87.26
EBITDA 123.38
Effective Tax Rate (%) 20.95
Particulars MAR 2024 (Values in Cr)
Revenue 579.63
Operating Expense 549.26
Net Profit 38.56
Net Profit Margin (%) 6.65
Earnings Per Share (EPS) 69.04
EBITDA 107.47
Effective Tax Rate (%) 30.52
Particulars MAR 2023 (Values in Cr)
Revenue 826.90
Operating Expense 731.90
Net Profit 83.48
Net Profit Margin (%) 10.09
Earnings Per Share (EPS) 149.46
EBITDA 165.05
Effective Tax Rate (%) 25.99
Particulars MAR 2022 (Values in Cr)
Revenue 599.11
Operating Expense 543.25
Net Profit 65.40
Net Profit Margin (%) 10.91
Earnings Per Share (EPS) 117.09
EBITDA 124.51
Effective Tax Rate (%) 22.36
Particulars MAR 2021 (Values in Cr)
Revenue 339.40
Operating Expense 331.08
Net Profit 23.31
Net Profit Margin (%) 6.86
Earnings Per Share (EPS) 41.74
EBITDA 64.46
Effective Tax Rate (%) 8.73
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1334.36
ROE % 7.75
ROCE % 9.99
Total Debt to Total Equity 0.15
EBITDA Margin 20.31
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1205.58
ROE % 6.12
ROCE % 9.11
Total Debt to Total Equity 0.21
EBITDA Margin 18.54
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1050.26
ROE % 15.59
ROCE % 19.42
Total Debt to Total Equity 0.26
EBITDA Margin 19.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 867.04
ROE % 15.14
ROCE % 16.95
Total Debt to Total Equity 0.29
EBITDA Margin 20.78
Particulars MAR 2021 (Values in Cr)
Book Value / Share 679.98
ROE % 6.49
ROCE % 7.48
Total Debt to Total Equity 0.32
EBITDA Margin 18.99
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1334.39
ROE % 7.68
ROCE % 9.90
Total Debt to Total Equity 0.15
EBITDA Margin 20.20
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1205.61
ROE % 6.12
ROCE % 9.11
Total Debt to Total Equity 0.21
EBITDA Margin 18.54
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1050.28
ROE % 15.59
ROCE % 19.42
Total Debt to Total Equity 0.26
EBITDA Margin 19.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 867.06
ROE % 15.14
ROCE % 16.95
Total Debt to Total Equity 0.29
EBITDA Margin 20.78
Particulars MAR 2021 (Values in Cr)
Book Value / Share 679.99
ROE % 6.49
ROCE % 7.48
Total Debt to Total Equity 0.33
EBITDA Margin 18.99
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 101.48
Total Assets 1000.54
Total Liabilities 1000.54
Total Equity 745.31
Share Outstanding 5585569
Price to Book Ratio 0.93
Return on Assets (%) 4.87
Return on Capital (%) 6.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.59
Total Assets 965.66
Total Liabilities 965.66
Total Equity 673.39
Share Outstanding 5585569
Price to Book Ratio 1.48
Return on Assets (%) 3.99
Return on Capital (%) 5.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 25.47
Total Assets 886.86
Total Liabilities 886.86
Total Equity 586.63
Share Outstanding 5585569
Price to Book Ratio 1.40
Return on Assets (%) 9.41
Return on Capital (%) 12.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 51.00
Total Assets 764.10
Total Liabilities 764.10
Total Equity 484.29
Share Outstanding 5585569
Price to Book Ratio 2.25
Return on Assets (%) 8.55
Return on Capital (%) 10.66
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 22.19
Total Assets 599.22
Total Liabilities 599.22
Total Equity 379.81
Share Outstanding 5585569
Price to Book Ratio 2.01
Return on Assets (%) 3.89
Return on Capital (%) 4.91
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 101.45
Total Assets 1000.55
Total Liabilities 1000.55
Total Equity 745.33
Share Outstanding 5585569
Price to Book Ratio 0.93
Return on Assets (%) 4.87
Return on Capital (%) 6.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.56
Total Assets 965.68
Total Liabilities 965.68
Total Equity 673.40
Share Outstanding 5585569
Price to Book Ratio 1.48
Return on Assets (%) 3.99
Return on Capital (%) 5.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 25.47
Total Assets 886.87
Total Liabilities 886.87
Total Equity 586.64
Share Outstanding 5585569
Price to Book Ratio 1.40
Return on Assets (%) 9.41
Return on Capital (%) 12.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 50.99
Total Assets 764.11
Total Liabilities 764.11
Total Equity 484.30
Share Outstanding 5585569
Price to Book Ratio 2.25
Return on Assets (%) 8.55
Return on Capital (%) 10.66
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 22.10
Total Assets 599.02
Total Liabilities 599.02
Total Equity 379.81
Share Outstanding 5585569
Price to Book Ratio 2.01
Return on Assets (%) 3.89
Return on Capital (%) 4.91
Particulars MAR 2025 (Values in Cr)
Net Income 61.65
Cash from Operations 144.10
Cash from Investing -30.46
Cash from Financing -56.16
Net change in Cash 48.43
Free Cash Flow 164.94
Particulars MAR 2024 (Values in Cr)
Net Income 55.51
Cash from Operations 109.69
Cash from Investing -31.52
Cash from Financing -63.68
Net change in Cash 2.58
Free Cash Flow 149.33
Particulars MAR 2023 (Values in Cr)
Net Income 112.79
Cash from Operations 146.56
Cash from Investing -13.02
Cash from Financing -93.90
Net change in Cash 3.90
Free Cash Flow 195.87
Particulars MAR 2022 (Values in Cr)
Net Income 84.24
Cash from Operations 69.83
Cash from Investing -70.10
Cash from Financing 9.21
Net change in Cash -13.79
Free Cash Flow 117.52
Particulars MAR 2021 (Values in Cr)
Net Income 25.54
Cash from Operations 38.27
Cash from Investing -16.75
Cash from Financing -2.69
Net change in Cash 15.05
Free Cash Flow 55.80
Particulars MAR 2025 (Values in Cr)
Net Income 61.65
Cash from Operations 144.10
Cash from Investing -30.46
Cash from Financing -56.16
Net change in Cash 48.43
Free Cash Flow 164.94
Particulars MAR 2024 (Values in Cr)
Net Income 55.51
Cash from Operations 109.70
Cash from Investing -31.56
Cash from Financing -63.68
Net change in Cash 2.54
Free Cash Flow 149.34
Particulars MAR 2023 (Values in Cr)
Net Income 112.80
Cash from Operations 146.56
Cash from Investing -13.02
Cash from Financing -93.90
Net change in Cash 3.90
Free Cash Flow 195.87
Particulars MAR 2022 (Values in Cr)
Net Income 84.24
Cash from Operations 69.83
Cash from Investing -70.10
Cash from Financing 9.21
Net change in Cash -13.79
Free Cash Flow 117.52
Particulars MAR 2021 (Values in Cr)
Net Income 25.54
Cash from Operations 38.18
Cash from Investing -16.75
Cash from Financing -2.69
Net change in Cash 14.97
Free Cash Flow 55.72
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 6329.95 37.29 3.32 18636.48 4882.00 / 8165.25
BASF INDIA LTD 4628.70 51.42 5.51 20035.62 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 330.05 46.55 1.67 1110.74 252.40 / 656.00
DEEPAK FERTILIZERS & PETR 1406.60 18.10 2.84 17756.61 888.25 / 1776.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 186.40 55.81 4.25 16.78 168.70 / 330.00
ATUL LTD 6329.95 41.90 3.36 18636.48 4882.00 / 8165.25
BASF INDIA LTD 4628.70 48.68 5.47 20035.62 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 330.05 27.14 1.63 1110.74 252.40 / 656.00

TRANSPEK INDUSTRY LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1399.05 -0.83 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 1425.00
  • 26 Days 1504.60
  • 10 Days 1444.80
  • 50 Days 1540.90
  • 12 Days 1453.20
  • 100 Days 1542.00
  • 20 Days 1485.50
  • 200 Days 1554.50
1421.90 PIVOT

First Support

1388.90

First Resistance

1443.80

Second Support

1367.00

Second Resistance

1476.80

Third Support

1334.00

Third Resistance

1498.70

RSI

34.19

ADX

44.05

MACD

-51.45

Williams % R

-72.86

Commodity Channel Index (CCI)

-74.45

Date

2025-09-01

Week

2035.00

Same Day

2018.00

Month

3208.00

1 Year

0.57

3 Year

0.54

Over 1 Month

-13.76%

down

Over 1 Year

-19.75%

down

Over 3 Months

-10.98%

down

Over 3 Years

-10.02%

down

Over 6 Months

10.80%

down

Over 5 Years

-2.97%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

TRANSPEK INDUSTRY LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

TRANSPEK INDUSTRY LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
26 Aug 2025 20.0 Final 26 Aug 2025 Equity shares
13 Sep 2024 14.0 Final 17 Sep 2024 Equity shares
21 Aug 2023 27.5 Final 22 Aug 2023 Equity shares
05 Sep 2022 22.5 Final 07 Sep 2022 Equity shares
06 Sep 2021 7.5 Final 08 Sep 2021 Equity shares
15 Sep 2020 2.5 Final 17 Sep 2020 Equity shares
05 Mar 2020 10.0 Interim 07 Mar 2020 Equity shares
01 Aug 2019 20.0 Final 03 Aug 2019 Equity shares
30 Jul 2018 9.0 Final 01 Aug 2018 Equity shares
08 Aug 2017 9.0 Final 10 Aug 2017 Equity shares
28 Jul 2016 7.5 Final 30 Jul 2016 Equity shares
10 Sep 2015 5.0 Final 14 Sep 2015 Equity shares
09 Sep 2014 2.5 Final 11 Sep 2014 Equity shares
31 Jul 2013 3.0 Final 02 Aug 2013 Equity shares
16 Aug 2011 4.0 Final 18 Aug 2011 Equity shares
04 Aug 2010 2.5 Final 06 Aug 2010 Equity shares
17 Aug 2009 2.5 Final 20 Aug 2009 Equity shares
12 Aug 2008 1.5 Final 14 Aug 2008 Equity shares
28 Aug 2007 1.5 Final 30 Aug 2007 Equity shares
05 Sep 2005 0.0 Final 08 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

TRANSPEK INDUSTRY LTD. Share Price

Transpek Industry Limited is a leading global supplier for chlorinated products to various industry sectors ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. The Company has an excellent experience in manufacturing of products using chlorinated chemistry presenting unending opportunities for supply of intermediates and speciality chemicals suitable for multiple applications. Presently, the Company is is into the manufacturing and export of a range of chemicals servicing the requirements of customers from a diverse range of industries - Textiles, Pharmaceuticals, Agrochemicals, Advanced Polymers, etc.

Established in October, 1965, Transpek Industry Limited (TIL) went public in Sep.'78. It started with the manufacture of acrylic plastic sheets at its plant at Atladra (Vadodra district), Gujarat. In 1969, Company discontinued manufacturing acrylic sheets and started manufacturing chemicals.

TIL started off with products like sodium hexameta phosphate, sodium tripoly phosphate, phosphoric acid, etc. In 1978, it expanded to manufacture sodium hydrosulphite (hydro), sodium formaldehyde sulphoxylate (safolite), thionyl chloride and sulphur dioxide, most of these being manufactured for the first time in India. TIL entered the global scenario in 1987 and is a government-recognised Export House.

The company manufactures a wide range of chemicals and intermediates which include sodium hydrosulphite, sodium formaldehyde sulphoxylate, zinc formaldehyde sulphoxylate (safolin), thionyl chloride, sulphur dichloride, rubber accelerators and the metals recovered include copper and zinc. It is the world's largest manufacturer of safolite and safolin and also India's only exporter of thionyl chloride and chloro acetyl chloride.

TIL expanded its capacities for rubber chemicals, sodium hydrosulphite and thionyl chloride and had set up a joint venture in China for thionyl chloride.In 1995-96, a new sulphur-di-oxide recovery and filling station was commissioned conforming to CCOE requirement. In 1996-97, it increased the installed capacity of Chlorinated Compounds to 16,200 tpa and in 1998-99, of rubber and related chemicals to 1,272 MT.

A MOU has been signed by the Company, its subsidiary Transpek Metals and Oxides Limited (TMOL) and SILOX. The Company has disinvested its holding in the above company from 39% to 14.93% to Excel Industries Ltd. During 2001-02 the Sulphoxylates Business of Transpek Industry was transferred to Transpek Metals and Oxides Ltd.

The company has expanded the installed capacity of Chlorinated Compound during the year 2003-04 by 2830 Tonnes and with this expansion,the total capacity has risen to 19700 Tonnes.

During the year 2004-05, the Company commissioned the business of Acid Chloride Plant. The Company's wholly owned subsidiary company viz. Transpek Marketing Ltd, was merged with Company and consequently, all its assets and liabilities were transferred to and vested in the Company through Scheme of Arrangement implemented effective from April 1, 2004, the Appointed Date during FY 2004-05.

In 2005 - 06, the Company improved technology for the manufacture of Thionyl Chloride ('TC') and as a result, increased the installed capacity of TC to19500 TPA. During year 2006-07, the installed capacity of Thionyl Chloride plant increased to 23% per annum. Continuous process improvements resulted in reduction in costs and in effluent and by-products generation. De-bottle-necking of the SO3 plant resulted in an increase in its capacity to 12% p.a. By strengthening R&D activities, three new products were added to the product slate of the Company during the year.

A wholly-owned subsidiary called Transpek Industry (Europe) Ltd. was established in the United Kingdom effective on April 24, 2008. During FY 2008-09, production was increased by capacity addition due to de-bottlenecking, efficiency improvement, recovery of products from residue, implementing newer techniques to handle process and adopting new techniques to convert by-products into value added products. Resultantly, these measures helped in increasing production, effecting saving in consumption of power and maintenance in market share.

The Company acquired 50% holding in a small pharma company, Sam Finechem Ltd (SFL) and accordingly, it deemed to be a subsidiary Company effective from 2010-11. During FY 2014-15, the Company divested its investments from Sam Fine O Chem Limited (SFOCL) and hence, SFOCL ceased to be the Subsidiary of the Company w.e.f. 03.01.2015. Later during FY 2019-20, the Company incorporated a Wholly Owned Subsidiary viz. Transpek Creative Chemistry Private Limited (TCCPL) on 6th January, 2020.

The Company has validated 3 new non-acid chloride products with the entry of new manufacturers. It has expanded the business operations to Japan, South America, and Eurasia, reflecting geographic diversification and R&D-led growth in FY 2025. Transpek has initiated
basic implementation of data analytics, ML, and AI models within its operations to enhance efficiency and decision-making in FY25.

Parent organization Indian Private
NSE symbol TRANSPEK
Founded 1965
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Transpek Industry Ltd?

Answer Field

Transpek Industry Ltd share price is for NSE ₹ 7.30 & for BSE ₹ 1,399.05 as on Sep 03 2025 11:42 AM.

What is the Market Cap of Transpek Industry Ltd Share?

Answer Field

The market cap of Transpek Industry Ltd for NSE ₹ 0.00 & for BSE ₹ 781.40 as on Sep 03 2025 11:42 AM.

What is the 52 Week High and Low of Transpek Industry Ltd?

Answer Field

The 52 Week High and Low of Transpek Industry Ltd for NSE is ₹ 7.75 and ₹ 0.00 and for BSE is ₹ 1,890.00 and ₹ 1,100.05.

What is 1 year return for Transpek Industry Ltd?

Answer Field

The 1 year returns on the stock has been -19.75%.

What is the P/E Ratio of Transpek Industry Ltd Share?

Answer Field

As on Sep 03 2025 11:42 AM the price-to-earnings (PE) ratio for Transpek Industry Ltd share is 14.32.

What is the PB ratio of Transpek Industry Ltd Share?

Answer Field

As on Sep 03 2025 11:42 AM, the price-to-book (PB) ratio for Transpek Industry Ltd share is 1334.39.

How to Buy Transpek Industry Ltd Share?

Answer Field

You can trade in Transpek Industry Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Transpek Industry Ltd Share on Bajaj Broking App?

Answer Field

To buy Transpek Industry Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Transpek Industry Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91